Global Orthopaedic Oncology Market Growth (Status and Outlook) 2023-2029

Global Orthopaedic Oncology Market Growth (Status and Outlook) 2023-2029

Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours.

LPI (LP Information)' newest research report, the “Orthopaedic Oncology Industry Forecast” looks at past sales and reviews total world Orthopaedic Oncology sales in 2022, providing a comprehensive analysis by region and market sector of projected Orthopaedic Oncology sales for 2023 through 2029. With Orthopaedic Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orthopaedic Oncology industry.

This Insight Report provides a comprehensive analysis of the global Orthopaedic Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopaedic Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orthopaedic Oncology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopaedic Oncology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopaedic Oncology.

The global Orthopaedic Oncology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Orthopaedic Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Orthopaedic Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Orthopaedic Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Orthopaedic Oncology players cover Stryker Corporation, Amgen Inc., Tyco Electronics UK Holdings Ltd., Accentus Inc., Canon Medical Systems, Siemens Healthineers, MD Anderson Cancer Center, Roche and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Orthopaedic Oncology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Surgery
Chemotherapy
Radiation Therapy
Targeted Therapy

Segmentation by application
Hospitals
Research Laboratories

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Stryker Corporation
Amgen Inc.
Tyco Electronics UK Holdings Ltd.
Accentus Inc.
Canon Medical Systems
Siemens Healthineers
MD Anderson Cancer Center
Roche
Novartis AG
Sanofi S.A.

Please note: The report will take approximately 2 business days to prepare and deliver.